You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Boston Scientific to buy software firm

Natick medical device maker Boston Scientific Corp. said Monday that it has agreed to buy Rhythmia Medical Inc., a Burlington developer of software used in medical procedures.

Boston Scientific will pay $90 million upfront and make as much as $175 million in milestone payments if Rhythmia meets regulatory, commercial, and sales targets over the next five years.

Continue reading below

While the parties entered into a definitive agreement, disclosed after US financial markets closed Monday, they said they expect to complete the transaction by Friday.

Rhythmia develops advanced mapping and navigation software for use in cardiac catheter ablations, a way to treat abnormal heart rhythms, and other electrophysiology procedures, including atrial fibrillation and atrial flutter. If its technology is approved by regulators in the United States and Europe, Boston Scientific said it expects to begin a limited market launch of the Rhythmia technology used with Boston Scientific’s catheters next year and full market launch in 2014.

Robert Weisman can be reached at weisman@globe.com.
Loading comments...
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.